SCHEMBL23347350

SCHEMBL23347350

Cc1ccccc1-c1cc2c3cc4c(cc3c(-c3ccccc3C)cc2c2cc3c(cc12)-c1cccc2c(-c5cccc6sc7ccccc7c56)ccc-3c12)-c1cccc2c(-c3cccc5sc6ccccc6c35)ccc-4c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 2/20 0.41
MAPT P10636 5/20 0.37
ALDH1A1 P00352 4/20 0.37
POLB P06746 2/20 0.37
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
KMT2A Q03164 1/20 0.37
KDM4E B2RXH2 2/20 0.36
PABPC1 P11940 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
BRDT Q58F21 1/20 0.36
GPR3 P46089 1/20 0.34
IDO1 P14902 1/20 0.34
TDO2 P48775 1/20 0.34
MAOB P27338 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
ALOX5 P09917 1/20 0.33
HCRTR1 O43613 1/20 0.33
LMNA P02545 1/20 0.33
NPC1 O15118 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23347348 0.91 IDO1 (0.36) SLC9A1MAPTALDH1A1POLBMEN1
SCHEMBL19001870 0.85 GPR3 (0.46) SLC9A1MAPTALDH1A1POLBMEN1
SCHEMBL21742520 0.84 GPR3 (0.45) SLC9A1MAPTALDH1A1POLBMEN1
SCHEMBL23347102 0.80 ALDH1A1 (0.48) MAPTALDH1A1POLBMEN1GAA
SCHEMBL23989062 0.79 MAPT (0.47) SLC9A1MAPTALDH1A1POLBMEN1
SCHEMBL18907473 0.77 GPR3 (0.41) MAPTALDH1A1POLBMEN1GAA
SCHEMBL23347418 0.77 ATM (0.37) MAPTALDH1A1GAAKDM4EPABPC1
SCHEMBL27388014 0.76 GPR3 (0.43) SLC9A1MAPTALDH1A1POLBMEN1
SCHEMBL26536448 0.76 IDO1 (0.45) SLC9A1MAPTALDH1A1POLBMEN1
SCHEMBL21742606 0.76 HTR7 (0.42) SLC9A1MAPTALDH1A1POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210143335-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CANON KABUSHIKI KAISHA (JP) 2021-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210143335-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT OR51E2, OR10J3, NR2E3 SLC9A1 825/4885MAPT 2062/4885ALDH1A1 151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.